Comparing Baraclude vs Viread
| Baraclude (entecavir) | Viread (tenofovir disoproxil) |
|
|---|
| Baraclude (entecavir) | Viread (tenofovir disoproxil) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hepatitis B. Baraclude may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatitis B, HIV Infection, Nonoccupational Exposure, Occupational Exposure. Viread may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Baraclude (entecavir) | More about Viread (tenofovir disoproxil) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Baraclude has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Viread has an average rating of 7.7 out of 10 from a total of 13 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Baraclude side effects |
View all Viread side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Baraclude prices |
View all Viread prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
149 hours |
180 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 159 drugs are known to interact with Baraclude:
|
A total of 242 drugs are known to interact with Viread:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 29, 2005 |
October 26, 2001 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Vemlidy
Vemlidy (tenofovir alafenamide) is an oral, once-daily, antiviral tablet that may be used to treat ...
Viread
Viread (tenofovir) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Epivir
Epivir (lamivudine) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Peginterferon alfa-2a
Peginterferon alfa-2a is used for hepatitis b, hepatitis c, polycythemia vera, thrombocythemia
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Lamivudine
Lamivudine is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational exposure
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.